Linatis M 2.5/500 Tablet is primarily used for managing type 2 diabetes mellitus, a chronic metabolic condition characterised by high blood glucose levels. It belongs to the class of antidiabetic medications.
Linatis M 2.5/500 Tablet is indicated for:
• Management of type 2 diabetes mellitus
• Reducing the risk of serious diabetes-related complications
• Slowing the progression of kidney damage
• Decreasing the likelihood of nerve problems
• Lowering the chance of limb loss due to diabetes
• Minimising the risk of heart disease and stroke associated with diabetes
• Swallow the tablet whole with water.
• Confirm the expiration date before ingestion.
• Do not crush or chew the tablet.
• Do not alter the dosage without professional guidance.
• Refrain from discontinuing the medicine without consulting your doctor.
Linatis M 2.5/500 Tablet is taken orally.
The potential side effects of Linatis M 2.5/500 Tablet include:
• Headache
• Nausea
• Hypoglycaemia
• Tremors (involuntary shaking or trembling movements)
• Dizziness
Linatis M 2.5/500 Tablet comprises two active pharmacological agents:
• Linagliptin (2.5 mg): This component is a dipeptidyl peptidase-4 (DPP-4) inhibitor that elevates incretin levels, thereby facilitating increased insulin secretion, particularly following meals.
• Metformin (500 mg): As a biguanide, it reduces liver glucose production and enhances the body’s sensitivity to insulin, thereby improving glycaemic control.
This tablet should be only used if clearly needed.
Nursing mothers should discontinue breastfeeding if this tablet is advised.
Alcohol consumption can elevate the risk of hypoglycaemia and lactic acidosis.
Not recommended in patients with liver impairment.
Contraindicated in patients with severe kidney impairment.
The medicine may induce dizziness or hypoglycaemia. Avoid operating heavy machinery or driving until you are sure of the medicine’s effects on your alertness.
Inform your doctor of any known allergies to linagliptin, metformin, or any other constituents of the tablet.
Not recommended for individuals under 18 years of age.
Elderly patients should use this medication under medical supervision due to their increased sensitivity to its side effects.
Drug-Drug Interactions
• Antidiabetic agents: Co-administration with insulin or sulfonylureas can increase the risk of hypoglycaemia.
• Antihypertensives: Certain antihypertensive medications may affect the efficacy of Linatis M 2.5/500 Tablet.
Drug-Disease Interactions
• Heart disease: The presence of heart disease may influence the medicine’s effectiveness.
Daily Dosage
• Linatis M 2.5/500 Tablet should be taken as directed by your doctor. Adhere strictly to the dosage prescribed based on your health status and response.
Missed Dose
• If a dose is missed, take it as soon as you remember. If it is close to the time of your next dose, skip the missed dose. Avoid doubling up on doses without consulting your doctor.
Overdose
• An overdose may exacerbate common side effects such as headaches, nausea, and dizziness. Immediate medical attention is required if overdose is suspected.
• Store Linatis M 2.5/500 Tablet at temperatures not exceeding 30°C.
• Protect from direct sunlight, heat, and moisture.
• Keep out of reach of children.
• Verify the expiry date before use.
• Maintain a balanced diet low in sugars and high in fibre.
• Engage in regular physical exercise, such as walking or cycling, to aid in blood glucose management and improve overall health.
.avif)
%20(1).png)
.webp)